Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Thyroidectomy | 157 | 2024 | 915 | 24.510 |
Why?
|
Thyroid Neoplasms | 145 | 2024 | 2360 | 17.870 |
Why?
|
Recurrent Laryngeal Nerve | 54 | 2024 | 145 | 12.540 |
Why?
|
Monitoring, Intraoperative | 59 | 2024 | 952 | 10.790 |
Why?
|
Vocal Cord Paralysis | 45 | 2024 | 275 | 10.380 |
Why?
|
Thyroid Gland | 60 | 2023 | 1172 | 8.270 |
Why?
|
Thyroid Nodule | 42 | 2024 | 766 | 7.240 |
Why?
|
Electromyography | 51 | 2024 | 1399 | 7.080 |
Why?
|
Parathyroid Glands | 26 | 2024 | 522 | 5.650 |
Why?
|
Parathyroidectomy | 26 | 2024 | 244 | 5.020 |
Why?
|
Carcinoma, Papillary | 31 | 2024 | 792 | 5.000 |
Why?
|
Laryngeal Nerves | 18 | 2021 | 57 | 4.970 |
Why?
|
Adenocarcinoma, Follicular | 15 | 2024 | 325 | 4.160 |
Why?
|
Otolaryngology | 24 | 2021 | 698 | 4.120 |
Why?
|
Vagus Nerve | 19 | 2024 | 460 | 4.110 |
Why?
|
Neck Dissection | 22 | 2024 | 201 | 3.700 |
Why?
|
Carcinoma | 17 | 2023 | 2341 | 2.640 |
Why?
|
Thyroid Diseases | 16 | 2024 | 388 | 2.530 |
Why?
|
Endocrine Surgical Procedures | 6 | 2023 | 32 | 2.430 |
Why?
|
Intraoperative Complications | 17 | 2020 | 1176 | 2.410 |
Why?
|
Hypoparathyroidism | 6 | 2023 | 136 | 2.280 |
Why?
|
Laryngeal Muscles | 10 | 2021 | 107 | 2.240 |
Why?
|
Neck | 14 | 2022 | 736 | 2.210 |
Why?
|
Larynx | 12 | 2021 | 492 | 2.030 |
Why?
|
Electric Stimulation | 7 | 2021 | 1743 | 1.920 |
Why?
|
Carcinoma, Papillary, Follicular | 5 | 2020 | 59 | 1.820 |
Why?
|
Goiter | 5 | 2019 | 87 | 1.680 |
Why?
|
Carcinoma, Neuroendocrine | 8 | 2024 | 342 | 1.670 |
Why?
|
Laryngoscopy | 16 | 2022 | 714 | 1.660 |
Why?
|
Electrodes | 6 | 2024 | 618 | 1.630 |
Why?
|
Endocrinology | 10 | 2021 | 443 | 1.630 |
Why?
|
Biopsy, Fine-Needle | 24 | 2022 | 1131 | 1.630 |
Why?
|
Iodine Radioisotopes | 15 | 2024 | 1035 | 1.510 |
Why?
|
Voice Disorders | 5 | 2021 | 286 | 1.480 |
Why?
|
Postoperative Complications | 35 | 2024 | 15880 | 1.390 |
Why?
|
Voice Quality | 4 | 2021 | 226 | 1.310 |
Why?
|
Lymphatic Metastasis | 23 | 2024 | 2930 | 1.300 |
Why?
|
Evidence-Based Medicine | 17 | 2023 | 3708 | 1.300 |
Why?
|
Humans | 313 | 2024 | 768451 | 1.150 |
Why?
|
Hyperparathyroidism, Primary | 5 | 2021 | 164 | 1.100 |
Why?
|
Thyroglobulin | 4 | 2015 | 111 | 1.090 |
Why?
|
Hypocalcemia | 4 | 2024 | 203 | 1.080 |
Why?
|
Consensus | 17 | 2024 | 3207 | 1.080 |
Why?
|
Otorhinolaryngologic Surgical Procedures | 5 | 2021 | 326 | 1.050 |
Why?
|
Practice Guidelines as Topic | 18 | 2024 | 7451 | 1.030 |
Why?
|
Cost-Benefit Analysis | 12 | 2022 | 5532 | 0.990 |
Why?
|
Reoperation | 12 | 2023 | 4342 | 0.980 |
Why?
|
Preoperative Care | 14 | 2021 | 2257 | 0.960 |
Why?
|
Calcitonin | 7 | 2020 | 329 | 0.950 |
Why?
|
Robotics | 4 | 2023 | 826 | 0.940 |
Why?
|
Lymph Nodes | 13 | 2024 | 3472 | 0.920 |
Why?
|
Parathyroid Neoplasms | 7 | 2021 | 244 | 0.900 |
Why?
|
Otorhinolaryngologic Diseases | 4 | 2019 | 97 | 0.900 |
Why?
|
Neoplasm Invasiveness | 15 | 2021 | 3637 | 0.890 |
Why?
|
Intubation, Intratracheal | 7 | 2024 | 1359 | 0.870 |
Why?
|
Parathyroid Diseases | 4 | 2020 | 46 | 0.870 |
Why?
|
Electrodiagnosis | 2 | 2014 | 149 | 0.860 |
Why?
|
Adenoma, Oxyphilic | 2 | 2024 | 152 | 0.850 |
Why?
|
Neoadjuvant Therapy | 3 | 2024 | 2896 | 0.810 |
Why?
|
Retrospective Studies | 71 | 2024 | 81834 | 0.790 |
Why?
|
Ultrasonography | 18 | 2024 | 5995 | 0.780 |
Why?
|
Cranial Nerve Injuries | 1 | 2021 | 28 | 0.760 |
Why?
|
Neoplasm Staging | 15 | 2024 | 11249 | 0.760 |
Why?
|
Neoplasm Recurrence, Local | 18 | 2023 | 9425 | 0.750 |
Why?
|
Fellowships and Scholarships | 3 | 2020 | 1134 | 0.750 |
Why?
|
Cranial Nerves | 1 | 2021 | 98 | 0.720 |
Why?
|
Needles | 1 | 2024 | 455 | 0.720 |
Why?
|
Tracheal Diseases | 1 | 2021 | 118 | 0.710 |
Why?
|
Head | 3 | 2021 | 927 | 0.680 |
Why?
|
Oxyphil Cells | 1 | 2020 | 56 | 0.680 |
Why?
|
Vagus Nerve Stimulation | 6 | 2019 | 229 | 0.670 |
Why?
|
Middle Aged | 93 | 2024 | 223418 | 0.670 |
Why?
|
Choristoma | 1 | 2021 | 205 | 0.670 |
Why?
|
Recovery of Function | 3 | 2024 | 2994 | 0.660 |
Why?
|
Surgical Sponges | 1 | 2019 | 40 | 0.650 |
Why?
|
Intraoperative Care | 3 | 2020 | 772 | 0.640 |
Why?
|
Male | 115 | 2024 | 364781 | 0.640 |
Why?
|
Physicians' Offices | 1 | 2019 | 60 | 0.630 |
Why?
|
Female | 128 | 2024 | 396943 | 0.620 |
Why?
|
Societies, Medical | 11 | 2019 | 3955 | 0.620 |
Why?
|
Aged | 72 | 2024 | 171520 | 0.620 |
Why?
|
Adult | 86 | 2024 | 223542 | 0.610 |
Why?
|
Iatrogenic Disease | 2 | 2019 | 552 | 0.600 |
Why?
|
Societies | 1 | 2018 | 107 | 0.590 |
Why?
|
Models, Educational | 1 | 2020 | 375 | 0.590 |
Why?
|
Nuclear Medicine | 1 | 2020 | 259 | 0.550 |
Why?
|
Interdisciplinary Communication | 6 | 2018 | 937 | 0.520 |
Why?
|
Thyroglossal Cyst | 1 | 2015 | 31 | 0.520 |
Why?
|
Glottis | 3 | 2015 | 214 | 0.500 |
Why?
|
Analgesics, Opioid | 3 | 2021 | 3837 | 0.490 |
Why?
|
Disease Transmission, Infectious | 1 | 2020 | 562 | 0.480 |
Why?
|
Terminology as Topic | 4 | 2016 | 1539 | 0.480 |
Why?
|
Electrophysiological Phenomena | 5 | 2016 | 309 | 0.480 |
Why?
|
Catheter Ablation | 4 | 2023 | 2775 | 0.480 |
Why?
|
Serial Publications | 1 | 2014 | 11 | 0.480 |
Why?
|
Foreign-Body Migration | 1 | 2016 | 220 | 0.470 |
Why?
|
Carcinoma, Medullary | 5 | 2011 | 116 | 0.470 |
Why?
|
Foreign Bodies | 1 | 2019 | 403 | 0.470 |
Why?
|
Pain, Postoperative | 3 | 2023 | 1763 | 0.470 |
Why?
|
Investments | 1 | 2016 | 149 | 0.460 |
Why?
|
Endoscopy | 5 | 2024 | 1857 | 0.460 |
Why?
|
United States | 35 | 2023 | 73121 | 0.450 |
Why?
|
Prospective Studies | 29 | 2021 | 54914 | 0.450 |
Why?
|
Ophthalmology | 1 | 2020 | 560 | 0.450 |
Why?
|
Workflow | 1 | 2018 | 861 | 0.440 |
Why?
|
Quality Improvement | 3 | 2018 | 3858 | 0.440 |
Why?
|
Spectroscopy, Near-Infrared | 3 | 2024 | 752 | 0.440 |
Why?
|
Carcinoid Tumor | 1 | 2015 | 226 | 0.440 |
Why?
|
Prognosis | 23 | 2024 | 30028 | 0.430 |
Why?
|
Internationality | 4 | 2021 | 1007 | 0.410 |
Why?
|
Occupations | 1 | 2015 | 519 | 0.410 |
Why?
|
Intestinal Neoplasms | 1 | 2015 | 317 | 0.410 |
Why?
|
Preoperative Period | 5 | 2020 | 564 | 0.400 |
Why?
|
Treatment Outcome | 29 | 2024 | 65409 | 0.400 |
Why?
|
Neuromuscular Blockade | 3 | 2020 | 148 | 0.400 |
Why?
|
Aged, 80 and over | 29 | 2024 | 59680 | 0.400 |
Why?
|
Hypoglossal Nerve | 3 | 2020 | 109 | 0.390 |
Why?
|
Minocycline | 1 | 2012 | 170 | 0.380 |
Why?
|
Monitoring, Physiologic | 3 | 2015 | 1795 | 0.380 |
Why?
|
Medical Oncology | 4 | 2022 | 2347 | 0.370 |
Why?
|
Indocyanine Green | 2 | 2023 | 239 | 0.370 |
Why?
|
Hyperpigmentation | 1 | 2012 | 116 | 0.370 |
Why?
|
Ultrasonography, Interventional | 3 | 2021 | 1519 | 0.370 |
Why?
|
Feedback | 2 | 2017 | 794 | 0.360 |
Why?
|
Lymph Node Excision | 6 | 2017 | 1276 | 0.360 |
Why?
|
Vocal Cords | 5 | 2018 | 520 | 0.350 |
Why?
|
Swine | 16 | 2024 | 5996 | 0.350 |
Why?
|
Diagnostic Tests, Routine | 2 | 2013 | 792 | 0.350 |
Why?
|
Graves Disease | 2 | 2022 | 239 | 0.350 |
Why?
|
Delphi Technique | 3 | 2021 | 879 | 0.350 |
Why?
|
Incidental Findings | 1 | 2015 | 699 | 0.340 |
Why?
|
Young Adult | 24 | 2024 | 60045 | 0.340 |
Why?
|
Equipment Design | 4 | 2021 | 3530 | 0.330 |
Why?
|
Algorithms | 10 | 2024 | 14158 | 0.330 |
Why?
|
Intestine, Small | 1 | 2015 | 1218 | 0.320 |
Why?
|
Neuroendocrine Tumors | 1 | 2015 | 649 | 0.310 |
Why?
|
Postoperative Period | 6 | 2021 | 1833 | 0.310 |
Why?
|
Respiration | 1 | 2015 | 1667 | 0.300 |
Why?
|
Dogs | 6 | 2016 | 3847 | 0.300 |
Why?
|
Radiology | 1 | 2021 | 2118 | 0.290 |
Why?
|
Diagnosis, Differential | 11 | 2019 | 13026 | 0.290 |
Why?
|
Quality of Life | 7 | 2023 | 13497 | 0.290 |
Why?
|
Program Evaluation | 1 | 2016 | 2508 | 0.280 |
Why?
|
Four-Dimensional Computed Tomography | 3 | 2020 | 142 | 0.280 |
Why?
|
Sensitivity and Specificity | 9 | 2023 | 14728 | 0.280 |
Why?
|
Diagnostic Imaging | 5 | 2021 | 3543 | 0.270 |
Why?
|
Disease Management | 2 | 2020 | 2533 | 0.270 |
Why?
|
Adolescent | 30 | 2024 | 89168 | 0.270 |
Why?
|
Guideline Adherence | 3 | 2016 | 2239 | 0.270 |
Why?
|
Decision Making | 7 | 2018 | 3961 | 0.270 |
Why?
|
Models, Animal | 8 | 2019 | 2126 | 0.270 |
Why?
|
Cytodiagnosis | 2 | 2020 | 452 | 0.270 |
Why?
|
Palpation | 3 | 2008 | 166 | 0.270 |
Why?
|
Anesthesiology | 2 | 2016 | 1137 | 0.270 |
Why?
|
Internship and Residency | 3 | 2022 | 5952 | 0.270 |
Why?
|
Models, Organizational | 1 | 2009 | 546 | 0.260 |
Why?
|
Pediatrics | 3 | 2020 | 3622 | 0.260 |
Why?
|
Head and Neck Neoplasms | 5 | 2022 | 2915 | 0.260 |
Why?
|
Ambulatory Surgical Procedures | 1 | 2010 | 470 | 0.250 |
Why?
|
Cell Transformation, Neoplastic | 2 | 2014 | 2847 | 0.250 |
Why?
|
Trachea | 3 | 2021 | 1095 | 0.250 |
Why?
|
Reaction Time | 3 | 2016 | 2102 | 0.240 |
Why?
|
Follow-Up Studies | 15 | 2019 | 39430 | 0.240 |
Why?
|
Patient Preference | 2 | 2024 | 948 | 0.240 |
Why?
|
Delivery of Health Care | 6 | 2022 | 5367 | 0.230 |
Why?
|
Private Practice | 1 | 2005 | 155 | 0.230 |
Why?
|
Genetic Testing | 1 | 2017 | 3586 | 0.230 |
Why?
|
Child | 19 | 2023 | 80863 | 0.220 |
Why?
|
Decision Support Techniques | 4 | 2020 | 2010 | 0.220 |
Why?
|
Probability | 3 | 2014 | 2483 | 0.220 |
Why?
|
Adhesives | 1 | 2024 | 67 | 0.220 |
Why?
|
Voice | 3 | 2015 | 268 | 0.210 |
Why?
|
Predictive Value of Tests | 10 | 2018 | 15460 | 0.210 |
Why?
|
Cervical Plexus | 2 | 2020 | 16 | 0.210 |
Why?
|
Tomography, X-Ray Computed | 15 | 2023 | 20762 | 0.210 |
Why?
|
Thyroiditis | 1 | 2023 | 86 | 0.210 |
Why?
|
Public Health | 1 | 2016 | 2693 | 0.200 |
Why?
|
Radiotherapy, Adjuvant | 2 | 2020 | 1794 | 0.200 |
Why?
|
Family Practice | 1 | 2005 | 510 | 0.200 |
Why?
|
Risk Assessment | 12 | 2024 | 24311 | 0.200 |
Why?
|
Databases, Factual | 7 | 2019 | 8081 | 0.200 |
Why?
|
Proto-Oncogene Proteins B-raf | 4 | 2023 | 2072 | 0.200 |
Why?
|
Postoperative Care | 3 | 2018 | 1481 | 0.200 |
Why?
|
Axilla | 2 | 2022 | 629 | 0.200 |
Why?
|
Republic of Korea | 2 | 2021 | 587 | 0.200 |
Why?
|
Hashimoto Disease | 1 | 2023 | 108 | 0.200 |
Why?
|
Hypercalcemia | 2 | 2021 | 423 | 0.190 |
Why?
|
Parathyroid Hormone | 5 | 2021 | 1804 | 0.190 |
Why?
|
Cricoid Cartilage | 1 | 2021 | 69 | 0.190 |
Why?
|
Goiter, Substernal | 2 | 2011 | 18 | 0.190 |
Why?
|
Thyroid Function Tests | 1 | 2022 | 289 | 0.180 |
Why?
|
Consensus Development Conferences as Topic | 1 | 2021 | 169 | 0.180 |
Why?
|
Anastomosis, Surgical | 2 | 2021 | 993 | 0.180 |
Why?
|
North Carolina | 2 | 2016 | 327 | 0.180 |
Why?
|
Equipment Safety | 2 | 2019 | 250 | 0.180 |
Why?
|
Medical Errors | 2 | 2019 | 1263 | 0.180 |
Why?
|
Markov Chains | 3 | 2020 | 977 | 0.180 |
Why?
|
Tumor Burden | 3 | 2016 | 1909 | 0.180 |
Why?
|
Latin America | 1 | 2021 | 416 | 0.180 |
Why?
|
Preventive Health Services | 1 | 2005 | 568 | 0.170 |
Why?
|
Tomography, Optical Coherence | 1 | 2013 | 2958 | 0.170 |
Why?
|
Reproducibility of Results | 10 | 2022 | 20231 | 0.170 |
Why?
|
Patient Positioning | 2 | 2020 | 332 | 0.170 |
Why?
|
Survival Analysis | 5 | 2018 | 10125 | 0.170 |
Why?
|
Immunohistochemistry | 3 | 2024 | 11138 | 0.170 |
Why?
|
Hospitals, Pediatric | 1 | 2009 | 1876 | 0.170 |
Why?
|
Electric Impedance | 1 | 2024 | 796 | 0.170 |
Why?
|
Bell Palsy | 1 | 2020 | 39 | 0.170 |
Why?
|
Jugular Veins | 1 | 2021 | 211 | 0.170 |
Why?
|
Quality-Adjusted Life Years | 4 | 2020 | 1734 | 0.170 |
Why?
|
Kazakhstan | 1 | 2019 | 19 | 0.170 |
Why?
|
gamma-Cyclodextrins | 2 | 2016 | 17 | 0.160 |
Why?
|
Molecular Diagnostic Techniques | 2 | 2021 | 614 | 0.160 |
Why?
|
Paranasal Sinus Diseases | 1 | 2000 | 121 | 0.160 |
Why?
|
Androstanols | 2 | 2016 | 47 | 0.160 |
Why?
|
Vascular Neoplasms | 1 | 2021 | 167 | 0.160 |
Why?
|
Quality Indicators, Health Care | 1 | 2009 | 1813 | 0.160 |
Why?
|
Hemostasis, Surgical | 1 | 2019 | 127 | 0.160 |
Why?
|
Quality Assurance, Health Care | 1 | 2009 | 2179 | 0.160 |
Why?
|
Gallstones | 1 | 2021 | 285 | 0.160 |
Why?
|
Salivary Glands | 1 | 2020 | 231 | 0.160 |
Why?
|
Hyperparathyroidism, Secondary | 1 | 2019 | 125 | 0.160 |
Why?
|
Wound Closure Techniques | 1 | 2019 | 88 | 0.160 |
Why?
|
Pilot Projects | 4 | 2024 | 8730 | 0.150 |
Why?
|
District of Columbia | 1 | 2018 | 159 | 0.150 |
Why?
|
Optics and Photonics | 1 | 2000 | 307 | 0.150 |
Why?
|
Spectrometry, Fluorescence | 1 | 2020 | 694 | 0.150 |
Why?
|
Laryngectomy | 2 | 2014 | 245 | 0.150 |
Why?
|
Neuromuscular Nondepolarizing Agents | 2 | 2016 | 145 | 0.150 |
Why?
|
Laryngoscopes | 1 | 2020 | 147 | 0.150 |
Why?
|
Cell Differentiation | 7 | 2024 | 11674 | 0.150 |
Why?
|
Risk | 4 | 2020 | 9642 | 0.150 |
Why?
|
Medical Illustration | 1 | 2019 | 135 | 0.150 |
Why?
|
Patient Selection | 3 | 2020 | 4266 | 0.150 |
Why?
|
Clinical Competence | 5 | 2021 | 4841 | 0.150 |
Why?
|
Cross-Sectional Studies | 14 | 2023 | 26351 | 0.150 |
Why?
|
Cholecystectomy | 2 | 2021 | 409 | 0.140 |
Why?
|
Brachial Plexus Neuropathies | 1 | 2019 | 124 | 0.140 |
Why?
|
Thyroid Cartilage | 1 | 2017 | 46 | 0.140 |
Why?
|
Specialties, Surgical | 1 | 2022 | 393 | 0.140 |
Why?
|
Animals | 24 | 2024 | 169418 | 0.140 |
Why?
|
Evoked Potentials, Somatosensory | 1 | 2019 | 247 | 0.140 |
Why?
|
Pancreatic Neoplasms | 1 | 2015 | 5442 | 0.140 |
Why?
|
Gastrins | 1 | 2017 | 75 | 0.140 |
Why?
|
Hematologic Tests | 1 | 2018 | 240 | 0.140 |
Why?
|
Organ Preservation | 1 | 2020 | 389 | 0.140 |
Why?
|
Contrast Media | 5 | 2020 | 5336 | 0.140 |
Why?
|
Mass Screening | 3 | 2020 | 5455 | 0.140 |
Why?
|
Gastric Acid | 1 | 2017 | 99 | 0.140 |
Why?
|
Natural Orifice Endoscopic Surgery | 1 | 2018 | 119 | 0.140 |
Why?
|
Gene Fusion | 1 | 2019 | 356 | 0.140 |
Why?
|
Signal Processing, Computer-Assisted | 2 | 2014 | 1496 | 0.140 |
Why?
|
Patient Care Team | 3 | 2018 | 2526 | 0.130 |
Why?
|
Hematoma | 2 | 2019 | 768 | 0.130 |
Why?
|
Nerve Block | 1 | 2023 | 711 | 0.130 |
Why?
|
Stroboscopy | 1 | 2016 | 62 | 0.130 |
Why?
|
Technetium Tc 99m Sestamibi | 3 | 2019 | 184 | 0.130 |
Why?
|
Facial Paralysis | 1 | 2020 | 346 | 0.130 |
Why?
|
Endocrine Gland Neoplasms | 1 | 2015 | 23 | 0.130 |
Why?
|
Lymphoma | 2 | 2022 | 1907 | 0.130 |
Why?
|
Esophagus | 2 | 2014 | 1045 | 0.130 |
Why?
|
Leadership | 2 | 2019 | 1395 | 0.130 |
Why?
|
Multiple Endocrine Neoplasia | 1 | 2015 | 25 | 0.130 |
Why?
|
RNA, Neoplasm | 1 | 2018 | 751 | 0.130 |
Why?
|
Education, Medical, Continuing | 2 | 2011 | 829 | 0.130 |
Why?
|
Pancreatic Polypeptide | 1 | 2015 | 35 | 0.130 |
Why?
|
Carcinoid Heart Disease | 1 | 2015 | 11 | 0.130 |
Why?
|
Gene Expression Profiling | 3 | 2022 | 9507 | 0.130 |
Why?
|
Incidence | 7 | 2022 | 21552 | 0.130 |
Why?
|
Chromogranin A | 1 | 2015 | 47 | 0.130 |
Why?
|
Prosthesis Implantation | 1 | 2020 | 595 | 0.120 |
Why?
|
Denervation | 1 | 2016 | 265 | 0.120 |
Why?
|
Flushing | 1 | 2015 | 52 | 0.120 |
Why?
|
Informed Consent | 1 | 2021 | 1012 | 0.120 |
Why?
|
Electronic Health Records | 3 | 2018 | 4877 | 0.120 |
Why?
|
North America | 1 | 2018 | 1292 | 0.120 |
Why?
|
Granuloma, Foreign-Body | 1 | 1995 | 42 | 0.120 |
Why?
|
Dissection | 1 | 2016 | 299 | 0.120 |
Why?
|
Perioperative Care | 2 | 2013 | 1046 | 0.120 |
Why?
|
Risk Factors | 13 | 2024 | 74915 | 0.120 |
Why?
|
Documentation | 1 | 2021 | 913 | 0.120 |
Why?
|
Medical History Taking | 1 | 2018 | 776 | 0.120 |
Why?
|
Cohort Studies | 8 | 2022 | 41797 | 0.120 |
Why?
|
Mesentery | 1 | 2015 | 202 | 0.120 |
Why?
|
General Surgery | 2 | 2019 | 1714 | 0.120 |
Why?
|
Risk Management | 1 | 2018 | 558 | 0.120 |
Why?
|
Octreotide | 1 | 2015 | 155 | 0.110 |
Why?
|
Polytetrafluoroethylene | 1 | 1995 | 245 | 0.110 |
Why?
|
Electric Stimulation Therapy | 1 | 2020 | 636 | 0.110 |
Why?
|
Surgical Instruments | 1 | 2016 | 386 | 0.110 |
Why?
|
Decision Trees | 3 | 2020 | 510 | 0.110 |
Why?
|
Recurrence | 4 | 2018 | 8510 | 0.110 |
Why?
|
Transcutaneous Electric Nerve Stimulation | 1 | 2016 | 170 | 0.110 |
Why?
|
Tracheotomy | 1 | 2014 | 168 | 0.110 |
Why?
|
Cross-Over Studies | 1 | 2020 | 2103 | 0.110 |
Why?
|
Medicare | 3 | 2023 | 6881 | 0.110 |
Why?
|
International Classification of Diseases | 1 | 2019 | 925 | 0.110 |
Why?
|
Interinstitutional Relations | 1 | 2014 | 236 | 0.110 |
Why?
|
Cholecalciferol | 1 | 2018 | 557 | 0.110 |
Why?
|
Branchial Region | 2 | 2010 | 36 | 0.110 |
Why?
|
Neoplasms, Multiple Primary | 1 | 2017 | 595 | 0.110 |
Why?
|
Somatostatin | 1 | 2015 | 448 | 0.110 |
Why?
|
Frozen Sections | 1 | 2013 | 155 | 0.110 |
Why?
|
Tongue | 1 | 2016 | 406 | 0.110 |
Why?
|
Medical Record Linkage | 1 | 2014 | 286 | 0.100 |
Why?
|
Ki-67 Antigen | 1 | 2015 | 631 | 0.100 |
Why?
|
Peptides, Cyclic | 1 | 2015 | 393 | 0.100 |
Why?
|
ras Proteins | 1 | 2018 | 1058 | 0.100 |
Why?
|
Liver Neoplasms | 2 | 2021 | 4362 | 0.100 |
Why?
|
RNA | 1 | 2022 | 2727 | 0.100 |
Why?
|
Neurosurgical Procedures | 2 | 2020 | 2097 | 0.100 |
Why?
|
Registries | 2 | 2021 | 8373 | 0.100 |
Why?
|
Safety Management | 1 | 2018 | 764 | 0.100 |
Why?
|
Randomized Controlled Trials as Topic | 2 | 2024 | 10358 | 0.100 |
Why?
|
Video-Assisted Surgery | 1 | 2012 | 51 | 0.100 |
Why?
|
Hypothyroidism | 1 | 2017 | 670 | 0.100 |
Why?
|
Radionuclide Imaging | 2 | 2014 | 1998 | 0.100 |
Why?
|
Specialization | 1 | 2016 | 782 | 0.100 |
Why?
|
Monte Carlo Method | 1 | 2017 | 1262 | 0.100 |
Why?
|
Random Allocation | 1 | 2016 | 2399 | 0.100 |
Why?
|
Mutation | 8 | 2024 | 30243 | 0.100 |
Why?
|
Self Efficacy | 1 | 2016 | 651 | 0.090 |
Why?
|
Access to Information | 1 | 2014 | 317 | 0.090 |
Why?
|
Anesthesia | 2 | 2021 | 1596 | 0.090 |
Why?
|
Venous Thrombosis | 1 | 2021 | 1318 | 0.090 |
Why?
|
Hospitals, University | 1 | 2013 | 569 | 0.090 |
Why?
|
Gene Rearrangement | 1 | 2016 | 1139 | 0.090 |
Why?
|
Faculty, Medical | 1 | 2019 | 1218 | 0.090 |
Why?
|
Calcium | 3 | 2021 | 5793 | 0.090 |
Why?
|
Esophagectomy | 1 | 2014 | 482 | 0.090 |
Why?
|
Cost Savings | 1 | 2016 | 916 | 0.090 |
Why?
|
Peripheral Nervous System | 1 | 2011 | 151 | 0.090 |
Why?
|
Transplantation, Autologous | 1 | 2015 | 2126 | 0.090 |
Why?
|
Vitamins | 1 | 2018 | 1638 | 0.080 |
Why?
|
Body Weight | 1 | 2020 | 4630 | 0.080 |
Why?
|
False Positive Reactions | 2 | 2009 | 962 | 0.080 |
Why?
|
Prevalence | 4 | 2019 | 15880 | 0.080 |
Why?
|
Qualitative Research | 1 | 2020 | 3115 | 0.080 |
Why?
|
Disease Models, Animal | 6 | 2024 | 18388 | 0.080 |
Why?
|
Diarrhea | 2 | 2015 | 1320 | 0.080 |
Why?
|
Selection Bias | 1 | 2011 | 360 | 0.080 |
Why?
|
Organ Transplantation | 1 | 2019 | 1177 | 0.080 |
Why?
|
Ethanol | 1 | 2015 | 1334 | 0.080 |
Why?
|
Preventive Medicine | 1 | 2010 | 245 | 0.080 |
Why?
|
Muscles | 1 | 2013 | 1582 | 0.080 |
Why?
|
Radiotherapy Dosage | 1 | 2015 | 2925 | 0.080 |
Why?
|
Evoked Potentials | 1 | 2015 | 1057 | 0.080 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2021 | 2331 | 0.080 |
Why?
|
Phenotype | 2 | 2024 | 16712 | 0.080 |
Why?
|
Neoplasm Metastasis | 3 | 2019 | 4931 | 0.080 |
Why?
|
Vitamin D Deficiency | 1 | 2018 | 1389 | 0.080 |
Why?
|
Primary Prevention | 1 | 2016 | 1189 | 0.080 |
Why?
|
Hyperthyroidism | 1 | 2010 | 295 | 0.080 |
Why?
|
Abdominal Pain | 1 | 2015 | 1070 | 0.080 |
Why?
|
Review Literature as Topic | 1 | 2011 | 354 | 0.080 |
Why?
|
Primary Health Care | 1 | 2005 | 4737 | 0.080 |
Why?
|
Rare Diseases | 1 | 2014 | 630 | 0.080 |
Why?
|
Chronic Disease | 1 | 2023 | 9382 | 0.070 |
Why?
|
Prostheses and Implants | 1 | 1995 | 1279 | 0.070 |
Why?
|
Patient Discharge | 1 | 2021 | 3471 | 0.070 |
Why?
|
Adenoma | 2 | 2010 | 2163 | 0.070 |
Why?
|
Health Personnel | 1 | 2021 | 3384 | 0.070 |
Why?
|
Feasibility Studies | 3 | 2018 | 5308 | 0.070 |
Why?
|
Reference Standards | 1 | 2011 | 1015 | 0.070 |
Why?
|
Uncertainty | 1 | 2012 | 758 | 0.070 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2016 | 2434 | 0.070 |
Why?
|
Sleep Apnea, Obstructive | 1 | 2020 | 1890 | 0.070 |
Why?
|
Decision Support Systems, Clinical | 1 | 2016 | 1176 | 0.070 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2863 | 0.070 |
Why?
|
Abscess | 1 | 2010 | 607 | 0.070 |
Why?
|
Organizational Innovation | 1 | 2009 | 540 | 0.070 |
Why?
|
Patient Participation | 1 | 2015 | 1450 | 0.060 |
Why?
|
Airway Obstruction | 1 | 2011 | 672 | 0.060 |
Why?
|
Calcinosis | 1 | 2014 | 1485 | 0.060 |
Why?
|
Health Status | 1 | 2018 | 4096 | 0.060 |
Why?
|
Population Surveillance | 1 | 2016 | 2601 | 0.060 |
Why?
|
Survival Rate | 3 | 2021 | 12875 | 0.060 |
Why?
|
Morbidity | 1 | 2010 | 1760 | 0.060 |
Why?
|
Bone Density | 1 | 2018 | 3561 | 0.060 |
Why?
|
Forecasting | 1 | 2014 | 2950 | 0.060 |
Why?
|
Europe | 2 | 2024 | 3439 | 0.060 |
Why?
|
Patient Education as Topic | 1 | 2015 | 2339 | 0.060 |
Why?
|
Cartilage | 1 | 2008 | 808 | 0.060 |
Why?
|
Genetic Variation | 1 | 2020 | 6610 | 0.060 |
Why?
|
Biopsy | 4 | 2017 | 6816 | 0.060 |
Why?
|
Deglutition Disorders | 1 | 2011 | 637 | 0.060 |
Why?
|
Speech, Alaryngeal | 1 | 2004 | 32 | 0.060 |
Why?
|
Efficiency, Organizational | 1 | 2009 | 699 | 0.060 |
Why?
|
Physicians | 2 | 2016 | 4615 | 0.060 |
Why?
|
Infant | 3 | 2021 | 36497 | 0.060 |
Why?
|
Kidney Transplantation | 1 | 2019 | 4285 | 0.060 |
Why?
|
Drainage | 1 | 2010 | 1179 | 0.060 |
Why?
|
Neck Muscles | 1 | 2004 | 100 | 0.060 |
Why?
|
Isometric Contraction | 1 | 2004 | 150 | 0.060 |
Why?
|
Larynx, Artificial | 1 | 2004 | 70 | 0.060 |
Why?
|
Combined Modality Therapy | 2 | 2008 | 8559 | 0.060 |
Why?
|
Pyrroles | 1 | 2010 | 1127 | 0.060 |
Why?
|
Sampling Studies | 1 | 2005 | 617 | 0.060 |
Why?
|
Receptors, Fibroblast Growth Factor | 1 | 2024 | 196 | 0.060 |
Why?
|
Proto-Oncogene Proteins | 1 | 2016 | 4534 | 0.060 |
Why?
|
Biomedical Research | 1 | 2019 | 3463 | 0.060 |
Why?
|
Suture Techniques | 1 | 2008 | 776 | 0.060 |
Why?
|
Radiopharmaceuticals | 2 | 2019 | 2731 | 0.050 |
Why?
|
Burns | 1 | 2015 | 1887 | 0.050 |
Why?
|
Reference Values | 1 | 2010 | 4941 | 0.050 |
Why?
|
Radiography | 1 | 2014 | 6995 | 0.050 |
Why?
|
Paraffin Embedding | 1 | 2024 | 306 | 0.050 |
Why?
|
Image Processing, Computer-Assisted | 1 | 2000 | 9066 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 1 | 1 | 2024 | 259 | 0.050 |
Why?
|
Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2024 | 213 | 0.050 |
Why?
|
Receptors, Calcium-Sensing | 1 | 2024 | 318 | 0.050 |
Why?
|
Phonation | 1 | 2004 | 220 | 0.050 |
Why?
|
Body Mass Index | 1 | 2020 | 13030 | 0.050 |
Why?
|
Propensity Score | 2 | 2021 | 1971 | 0.050 |
Why?
|
Nerve Transfer | 1 | 2004 | 133 | 0.050 |
Why?
|
Lead Poisoning | 1 | 2005 | 323 | 0.050 |
Why?
|
Quality of Health Care | 3 | 2017 | 4340 | 0.050 |
Why?
|
Action Potentials | 1 | 2010 | 1837 | 0.050 |
Why?
|
Early Detection of Cancer | 1 | 2016 | 3230 | 0.050 |
Why?
|
Child, Preschool | 7 | 2023 | 42623 | 0.050 |
Why?
|
Indoles | 1 | 2010 | 1834 | 0.050 |
Why?
|
Publishing | 1 | 2009 | 836 | 0.050 |
Why?
|
Hyperparathyroidism | 2 | 2020 | 339 | 0.050 |
Why?
|
Antithyroid Agents | 1 | 2021 | 72 | 0.050 |
Why?
|
Ablation Techniques | 2 | 2015 | 249 | 0.050 |
Why?
|
Patient Readmission | 3 | 2022 | 3308 | 0.050 |
Why?
|
History, 21st Century | 2 | 2021 | 1575 | 0.050 |
Why?
|
Adipose Tissue | 1 | 2013 | 3335 | 0.050 |
Why?
|
Matched-Pair Analysis | 1 | 2021 | 286 | 0.050 |
Why?
|
GTP Phosphohydrolases | 1 | 2024 | 525 | 0.050 |
Why?
|
Survivors | 2 | 2023 | 2381 | 0.050 |
Why?
|
Immunization | 1 | 2005 | 1220 | 0.050 |
Why?
|
Comorbidity | 3 | 2022 | 10601 | 0.040 |
Why?
|
ROC Curve | 2 | 2018 | 3624 | 0.040 |
Why?
|
Sex Factors | 3 | 2020 | 10647 | 0.040 |
Why?
|
Publication Bias | 1 | 2020 | 160 | 0.040 |
Why?
|
Healthcare Disparities | 1 | 2015 | 3412 | 0.040 |
Why?
|
Magnetic Resonance Imaging | 4 | 2019 | 36840 | 0.040 |
Why?
|
Proto-Oncogenes | 1 | 2000 | 323 | 0.040 |
Why?
|
Sex Ratio | 1 | 2019 | 107 | 0.040 |
Why?
|
Head Movements | 1 | 2020 | 153 | 0.040 |
Why?
|
Molecular Probes | 1 | 2020 | 310 | 0.040 |
Why?
|
Thyrotropin | 2 | 2013 | 834 | 0.040 |
Why?
|
DNA Mutational Analysis | 2 | 2018 | 4120 | 0.040 |
Why?
|
Abortion, Induced | 2 | 1975 | 475 | 0.040 |
Why?
|
Artificial Intelligence | 2 | 2024 | 2659 | 0.040 |
Why?
|
Palatine Tonsil | 1 | 1999 | 193 | 0.040 |
Why?
|
Cultural Diversity | 1 | 2022 | 373 | 0.040 |
Why?
|
Obesity | 1 | 2020 | 13065 | 0.040 |
Why?
|
Carbazoles | 1 | 2019 | 221 | 0.040 |
Why?
|
Choice Behavior | 1 | 2024 | 846 | 0.040 |
Why?
|
Piperidines | 2 | 2019 | 1664 | 0.040 |
Why?
|
Neoplasms, Unknown Primary | 1 | 1999 | 101 | 0.040 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 2 | 2015 | 1142 | 0.040 |
Why?
|
Facial Nerve | 1 | 2020 | 277 | 0.040 |
Why?
|
Medically Uninsured | 1 | 2023 | 841 | 0.040 |
Why?
|
Gastric Acidity Determination | 1 | 2017 | 56 | 0.040 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2006 | 2048 | 0.040 |
Why?
|
Japan | 1 | 2021 | 1418 | 0.040 |
Why?
|
Thinness | 1 | 2020 | 483 | 0.030 |
Why?
|
Brachial Plexus | 1 | 2019 | 173 | 0.030 |
Why?
|
Attitude of Health Personnel | 1 | 2011 | 3922 | 0.030 |
Why?
|
Guidelines as Topic | 2 | 2014 | 1395 | 0.030 |
Why?
|
Medically Underserved Area | 1 | 2019 | 266 | 0.030 |
Why?
|
Heart Rate, Fetal | 1 | 1997 | 76 | 0.030 |
Why?
|
Medicaid | 2 | 2023 | 2843 | 0.030 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2024 | 1766 | 0.030 |
Why?
|
Disease-Free Survival | 2 | 2020 | 6856 | 0.030 |
Why?
|
Efficiency | 1 | 2019 | 477 | 0.030 |
Why?
|
Analgesics | 1 | 2023 | 1070 | 0.030 |
Why?
|
Resource Allocation | 1 | 2018 | 353 | 0.030 |
Why?
|
Cardiovascular Diseases | 1 | 2022 | 15638 | 0.030 |
Why?
|
Perfusion | 1 | 2020 | 1402 | 0.030 |
Why?
|
Bibliometrics | 1 | 2019 | 354 | 0.030 |
Why?
|
Anemia | 1 | 2005 | 1521 | 0.030 |
Why?
|
Prostaglandins F | 1 | 1975 | 80 | 0.030 |
Why?
|
Patient Care Management | 1 | 2018 | 304 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2020 | 2932 | 0.030 |
Why?
|
Likelihood Functions | 1 | 2018 | 993 | 0.030 |
Why?
|
Pathology, Surgical | 1 | 2016 | 151 | 0.030 |
Why?
|
Research Design | 1 | 2011 | 6217 | 0.030 |
Why?
|
Contraceptive Devices | 1 | 1974 | 25 | 0.030 |
Why?
|
Myosins | 1 | 2016 | 409 | 0.030 |
Why?
|
Ligation | 1 | 2015 | 447 | 0.030 |
Why?
|
Surgicenters | 1 | 2014 | 50 | 0.030 |
Why?
|
Uterine Contraction | 1 | 1975 | 91 | 0.030 |
Why?
|
Methadone | 1 | 1997 | 322 | 0.030 |
Why?
|
Florida | 1 | 2015 | 430 | 0.030 |
Why?
|
Models, Biological | 1 | 2010 | 9505 | 0.030 |
Why?
|
Area Under Curve | 1 | 2018 | 1640 | 0.030 |
Why?
|
Cytoskeletal Proteins | 1 | 2019 | 1337 | 0.030 |
Why?
|
Abnormalities, Drug-Induced | 1 | 1997 | 341 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2015 | 681 | 0.030 |
Why?
|
Prostaglandins | 1 | 1974 | 398 | 0.030 |
Why?
|
Perioperative Period | 1 | 2014 | 252 | 0.030 |
Why?
|
Life Expectancy | 1 | 2020 | 1249 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2019 | 13708 | 0.030 |
Why?
|
Travel | 1 | 2019 | 800 | 0.030 |
Why?
|
Motivation | 1 | 2023 | 2034 | 0.030 |
Why?
|
Health Plan Implementation | 1 | 2016 | 338 | 0.030 |
Why?
|
Ohio | 1 | 2013 | 328 | 0.030 |
Why?
|
Expert Testimony | 1 | 2014 | 266 | 0.030 |
Why?
|
Ear Neoplasms | 2 | 1992 | 118 | 0.020 |
Why?
|
Tuberculosis | 1 | 2005 | 2030 | 0.020 |
Why?
|
Multiple Endocrine Neoplasia Type 2a | 1 | 2011 | 40 | 0.020 |
Why?
|
Body Temperature | 1 | 2015 | 781 | 0.020 |
Why?
|
Observer Variation | 1 | 2018 | 2622 | 0.020 |
Why?
|
Socioeconomic Factors | 2 | 2016 | 7863 | 0.020 |
Why?
|
Hearing Loss | 1 | 2019 | 786 | 0.020 |
Why?
|
Length of Stay | 2 | 2019 | 6521 | 0.020 |
Why?
|
Lymphatic Diseases | 1 | 2013 | 320 | 0.020 |
Why?
|
Hypothermia, Induced | 1 | 2016 | 756 | 0.020 |
Why?
|
Immunoglobulin G | 1 | 2023 | 4572 | 0.020 |
Why?
|
Ear Canal | 1 | 1992 | 149 | 0.020 |
Why?
|
Atrophy | 1 | 2016 | 1648 | 0.020 |
Why?
|
Insurance, Health | 1 | 2023 | 2513 | 0.020 |
Why?
|
Demography | 1 | 2015 | 1643 | 0.020 |
Why?
|
Carcinoembryonic Antigen | 1 | 2011 | 338 | 0.020 |
Why?
|
Cell Nucleus Size | 1 | 2010 | 10 | 0.020 |
Why?
|
Cell Nucleus Shape | 1 | 2010 | 16 | 0.020 |
Why?
|
Weight Gain | 1 | 2020 | 2357 | 0.020 |
Why?
|
Hypopharynx | 1 | 2010 | 53 | 0.020 |
Why?
|
Polyps | 1 | 1992 | 200 | 0.020 |
Why?
|
Anesthesia, General | 1 | 2017 | 1185 | 0.020 |
Why?
|
Philosophy, Medical | 1 | 2010 | 79 | 0.020 |
Why?
|
Seroma | 1 | 2010 | 74 | 0.020 |
Why?
|
Intraoperative Period | 1 | 2010 | 513 | 0.020 |
Why?
|
Nervous System | 1 | 2013 | 547 | 0.020 |
Why?
|
Receptors, Vascular Endothelial Growth Factor | 1 | 2013 | 665 | 0.020 |
Why?
|
Overweight | 1 | 2020 | 2428 | 0.020 |
Why?
|
Cell Nucleolus | 1 | 2010 | 156 | 0.020 |
Why?
|
Fetus | 1 | 1997 | 1883 | 0.020 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2024 | 5342 | 0.020 |
Why?
|
Neoplastic Syndromes, Hereditary | 1 | 2011 | 249 | 0.020 |
Why?
|
Sex Distribution | 1 | 2014 | 2286 | 0.020 |
Why?
|
Nasal Cavity | 1 | 1991 | 309 | 0.020 |
Why?
|
Nose Neoplasms | 1 | 1991 | 250 | 0.020 |
Why?
|
Paranasal Sinus Neoplasms | 1 | 1991 | 243 | 0.020 |
Why?
|
Cell Shape | 1 | 2010 | 371 | 0.020 |
Why?
|
Regression Analysis | 1 | 2018 | 6353 | 0.020 |
Why?
|
Technology Assessment, Biomedical | 1 | 2010 | 308 | 0.020 |
Why?
|
Cell Size | 1 | 2010 | 626 | 0.020 |
Why?
|
Membrane Proteins | 1 | 2024 | 7895 | 0.020 |
Why?
|
Developing Countries | 1 | 2020 | 2901 | 0.020 |
Why?
|
Pharynx | 1 | 2010 | 436 | 0.020 |
Why?
|
Kidney Failure, Chronic | 1 | 2019 | 2489 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2016 | 10784 | 0.020 |
Why?
|
Proto-Oncogene Proteins c-ret | 1 | 2008 | 228 | 0.020 |
Why?
|
International Cooperation | 1 | 2013 | 1439 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2014 | 1514 | 0.020 |
Why?
|
Quinazolines | 1 | 2013 | 1376 | 0.020 |
Why?
|
Research | 1 | 2015 | 1984 | 0.020 |
Why?
|
Standard of Care | 1 | 2010 | 571 | 0.020 |
Why?
|
Health Expenditures | 1 | 2019 | 2391 | 0.020 |
Why?
|
False Negative Reactions | 1 | 2007 | 575 | 0.020 |
Why?
|
Cell Count | 1 | 2010 | 1835 | 0.020 |
Why?
|
Hyperplasia | 1 | 2008 | 1154 | 0.020 |
Why?
|
Radiotherapy | 1 | 2012 | 1510 | 0.020 |
Why?
|
History, 20th Century | 1 | 2013 | 2772 | 0.020 |
Why?
|
Muscle Denervation | 1 | 2004 | 60 | 0.010 |
Why?
|
Mesothelioma | 1 | 1991 | 811 | 0.010 |
Why?
|
Sound Spectrography | 1 | 2004 | 114 | 0.010 |
Why?
|
Functional Laterality | 1 | 2010 | 2268 | 0.010 |
Why?
|
Speech Acoustics | 1 | 2004 | 155 | 0.010 |
Why?
|
Statistics as Topic | 1 | 2010 | 2362 | 0.010 |
Why?
|
Chemotherapy, Adjuvant | 1 | 2012 | 3550 | 0.010 |
Why?
|
Time Factors | 3 | 2014 | 40271 | 0.010 |
Why?
|
Carcinoma, Squamous Cell | 1 | 1999 | 4083 | 0.010 |
Why?
|
Age Factors | 2 | 2016 | 18478 | 0.010 |
Why?
|
Communication | 1 | 2017 | 3910 | 0.010 |
Why?
|
Physician-Patient Relations | 1 | 2015 | 3267 | 0.010 |
Why?
|
Internet | 1 | 2014 | 3123 | 0.010 |
Why?
|
Linear Models | 1 | 2011 | 5880 | 0.010 |
Why?
|
Oxytocin | 2 | 1975 | 402 | 0.010 |
Why?
|
Progesterone | 2 | 1975 | 750 | 0.010 |
Why?
|
Caregivers | 1 | 2012 | 2302 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 2010 | 2643 | 0.010 |
Why?
|
Heart Rate | 1 | 2010 | 4218 | 0.010 |
Why?
|
Nerve Regeneration | 1 | 2004 | 801 | 0.010 |
Why?
|
Multivariate Analysis | 1 | 2011 | 12096 | 0.010 |
Why?
|
Logistic Models | 1 | 2011 | 13324 | 0.010 |
Why?
|
Hospitalization | 1 | 2016 | 10845 | 0.010 |
Why?
|
Suppositories | 1 | 1974 | 16 | 0.010 |
Why?
|
Stimulation, Chemical | 1 | 1974 | 306 | 0.010 |
Why?
|
Maternal-Fetal Exchange | 1 | 1997 | 462 | 0.010 |
Why?
|
Pregnancy Trimester, Third | 1 | 1997 | 583 | 0.010 |
Why?
|
Melanoma | 1 | 1992 | 5740 | 0.010 |
Why?
|
Infant, Newborn | 2 | 2007 | 26395 | 0.010 |
Why?
|
Pregnancy Trimester, Second | 1 | 1975 | 738 | 0.010 |
Why?
|
Nausea | 1 | 1974 | 682 | 0.010 |
Why?
|
Parity | 1 | 1974 | 939 | 0.010 |
Why?
|
Vomiting | 1 | 1974 | 655 | 0.010 |
Why?
|
Pressure | 1 | 1974 | 1173 | 0.010 |
Why?
|
Cervix Uteri | 1 | 1975 | 577 | 0.010 |
Why?
|
Uterus | 1 | 1974 | 660 | 0.010 |
Why?
|
Muscle Contraction | 1 | 1974 | 1208 | 0.010 |
Why?
|
Catheterization | 1 | 1975 | 1431 | 0.010 |
Why?
|
Pregnancy | 3 | 1997 | 30179 | 0.010 |
Why?
|
Exercise Test | 1 | 1997 | 2186 | 0.000 |
Why?
|
Skull Neoplasms | 1 | 1969 | 173 | 0.000 |
Why?
|
Fever | 1 | 1974 | 1622 | 0.000 |
Why?
|
Pregnancy Outcome | 1 | 1997 | 2959 | 0.000 |
Why?
|
Temporal Bone | 1 | 1969 | 683 | 0.000 |
Why?
|
Placenta | 1 | 1974 | 1724 | 0.000 |
Why?
|
Lymphoma, Non-Hodgkin | 1 | 1969 | 1376 | 0.000 |
Why?
|
Case-Control Studies | 1 | 1997 | 22293 | 0.000 |
Why?
|
Vestibulocochlear Nerve | 1 | 1969 | 115 | 0.000 |
Why?
|
Vestibular Nerve | 1 | 1969 | 101 | 0.000 |
Why?
|
Audiometry | 1 | 1969 | 253 | 0.000 |
Why?
|
Cochlear Nerve | 1 | 1969 | 202 | 0.000 |
Why?
|